GrowingStockReport.com

NASDAQ Decliners Watch List: Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Facebook, Inc. (NASDAQ:FB) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 

New York, NY -- (ReleaseWire) -- 02/05/2014 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Facebook, Inc. (NASDAQ:FB).

Halozyme Therapeutics, Inc. (NASDAQ:HALO) a biopharmaceutical company that engages in the research, development, and commercialization of human enzymes is currently down (-6.97%) on 5,443,117 shares traded after Halozyme Therapeutics priced 7,692,307 shares of common stock at $13.00. Halozyme Therapeutics, Inc. (NASDAQ:HALO) is currently down (-27.61%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Facebook, Inc. (NASDAQ:FB) operates as a social networking company worldwide is currently down (-1.51%) on 11,615,569 shares traded after Facebook Announced to Participate in the Goldman Sachs Technology and Internet Conference on February 11, 2014. Facebook, Inc. (NASDAQ:FB) is currently down (-2.59%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Facebook, Inc. (NASDAQ:FB)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com